Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01423019 · ClinicalTrials.gov registry record · NA

A Comparative Effectiveness Study Evaluating the Effects of Thermogenic Supplements on Body Composition

A NA study of Weight Loss, sponsored by Integrative Health Technologies.

Completed
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT01423019 is a NA study of Weight Loss that has completed, run by Integrative Health Technologies. The registered enrollment target is 75 participants, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01423019, a NA study of Weight Loss, has completed, sponsored by Integrative Health Technologies.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether subjects taking a supplement designed to increase metabolic rate will have a positive effect on body composition (fat mass, muscle mass, and bone density.)

Conditions Studied

Interventions

  • OTHER Sugar pill
  • DIETARY_SUPPLEMENT Advantra Z
  • DIETARY_SUPPLEMENT Advantra Z + Naringin + Hesperiden

Study Locations (1)

Texas

  • Integrative Health Technologies, Inc. - San Antonio

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2011-10
Est. Completion 2012-01
Phase NA

Sponsor

Integrative Health Technologies

3 total trials

What the Registry Record Tells You About NCT01423019

The ClinicalTrials.gov registry entry for NCT01423019 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (95% lower). The listed sponsor is Integrative Health Technologies, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Weight Loss appearing as the primary indexed condition, and to 3 interventions - of which Sugar pill is the first listed.

NCT01423019 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01423019 about?

NCT01423019 is a clinical study titled "A Comparative Effectiveness Study Evaluating the Effects of Thermogenic Supplements on Body Composition". The purpose of this study is to determine whether subjects taking a supplement designed to increase metabolic rate will have a positive effect on body composition (fat mass, muscle mass, and bone density.)

What is the current status of trial NCT01423019?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2011-10. Estimated completion is 2012-01.

What conditions does trial NCT01423019 study?

This clinical trial studies the following conditions: Weight Loss.

What interventions are being tested in trial NCT01423019?

The interventions under investigation include: Sugar pill (OTHER), Advantra Z (DIETARY_SUPPLEMENT), Advantra Z + Naringin + Hesperiden (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01423019?

This trial is sponsored by Integrative Health Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01423019 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Weight Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.